Patients with allergy background should not use Singclean Viscoelastic Solution for Ophthalmic Surgery.
Overfilling the eye anterior or posterior segment with Singclean Viscoelastic Solution for Ophthalmic Surgery may lead to increased intraocular pressure, glaucoma, or other ocular damage.
Postoperative intraocular pressure may also be elevated as result of pre-existing glaucoma, compromised outflow and by operative procedure and sequel a thereto, including enzymatic zonulysis, absence of an indectomy, trauma to filtration structures, and by blood and lenticular remnants in the anterior chamber.
lt is difficult to predict the exact role of these factors in any individual case, therefore the following precautions are recommended:
·Never overfill the eye chambers with Singclean Viscoelastic Solution for Ophthalmic Surgery (except in glaucoma surgery).
·ln posterior segment procedures in the aphakic diabetic patients, special care should be exercised to avoid using large amounts of Singclean Viscoelastic Solution for Ophthalmic Surgery.
·Remove all remain Singclean Viscoelastic Solution for Ophthalmic Surgery by irrigation and /or aspiration at the close of surgery (except in glaucoma surgery).
·Carefully monitor the intraocular pressure especially during the immediate postoperative period. If significant rises are observed, treat with appropriate therapy.
·Singclean Viscoelastic Solution for Ophthalmic Surgery is obtained from microbial fermentation by a highly purified proprietary process. The physician should be aware of potential allergic risks that can occur with the injection of any biological material.
·Needle is for single use only.
·Avoid trapping air bubble.
·On rare occasion, viscoelastic Singclean Viscoelastic Solution for Ophthalmic Surgery containing sodium hyaluronate has been observed to become slightly opaque or to form a slight precipitated upon instillation into the eye. Should this be observed, the cloudy or precipitated material should be removed by irrigation and/or aspiration.
·Use only when material is clear.
Singclean Viscoelastic Solution for Ophthalmic Surgery is extremely well tolerated after injection into human eyes. A transient rise of intraocular pressure postoperatively has been reported in some cases. In posterior segment surgery intraocular pressure rise have been reported in some patients, especially in aphakic diabetics, after injection of large amounts of Singclean Viscoelastic Solution for Ophthalmic Surgery.
Rarely, postoperative inflammatory reactions (iritis, hypopyon) as well as incidents of corneal edema and corneal decompensation have been reported. Their relationship to Singclean Viscoelastic Solution for Ophthalmic Surgery has not been established.
Direction for Use:
First expulse the air out of the ophthalmic Luer-lock needle, then inject Singclean Viscoelastic Solution for Ophthalmic Surgery appropriately into eye. The injected amount must be adapted to the type of surgical procedures. The administration of Singclean Viscoelastic Solution for Ophthalmic Surgery should be performed only by trained specialists.
The needle should fit to the syringe Luer tip (shown in figure 1); however, over tightening may cause the hub to weaken and possibly detach from the syringe. Extrusion of a test droplet is recommended prior to entering eye, and excessive force on the plunger should be avoided.
There is an incompatibility between sodium hyaluronate and solutions containing quaternary ammoniums, like benzalkonium chloride. In that case Singclean Viscoelastic Solution for Ophthalmic Surgery shall not be in contact with medico chirurgical materials rinsed with such a solution or with ophthalmic topics containing a quaternary ammonium as a preserving agent.
·The product is sterilized and free from pyrogenicity, and must be operated in a sterile environment;
·lt is for single use only. Any remaining sodium hyaluronate should be discarded. Do not use if sterile packaging has been damaged;
·The syringe is composed by glass. Be careful in using.
·Singclean Viscoelastic Solution for Ophthalmic Surgery must not be in contact with drugs containing benzalkonium chloride in order to avoid chaos;
·Must not be used for intravenous injection;
Store between 2℃ and 20℃, do not freeze. Relative humidity no more than 80%, well ventilated and clean, no corrosive gas , protect from light. Do not injection after expiry date.
This product is intended to aid anterior or posterior segment ophthalmic surgery, including:
Cataract extraction with/without implantation of intraocular lens;
Corneal transplant surgery;
Glaucoma filtering surgery;
Secondary lens implantation.